| 1 |
Khoza LJ, Kumar P, Dube A, Demana PH, Choonara YE. Insights into Innovative Therapeutics for Drug-Resistant Tuberculosis: Host-Directed Therapy and Autophagy Inducing Modified Nanoparticles. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121893] [Reference Citation Analysis]
|
| 2 |
Thudium RF, Hughes NLP, Afzal S, Çolak Y, Gelpi M, Knudsen AD, Kirkegaard-Klitbo DM, Borges ÁH, Gerstoft J, Nordestgaard BG, Vestbo J, Lundgren J, Ronit A, Nielsen SD. Fraction of Exhaled Nitric Oxide Levels Are Elevated in People Living With Human Immunodeficiency Virus Compared to Uninfected Controls, Suggesting Increased Eosinophilic Airway Inflammation. Clin Infect Dis 2020;71:3214-21. [PMID: 31900471 DOI: 10.1093/cid/ciz1223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Park JH, Shim D, Kim KES, Lee W, Shin SJ. Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against Mycobacterium tuberculosis Infection. Front Cell Infect Microbiol 2021;11:635335. [PMID: 33796480 DOI: 10.3389/fcimb.2021.635335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Crowther RR, Qualls JE. Metabolic Regulation of Immune Responses to Mycobacterium tuberculosis: A Spotlight on L-Arginine and L-Tryptophan Metabolism. Front Immunol 2020;11:628432. [PMID: 33633745 DOI: 10.3389/fimmu.2020.628432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 5 |
Sousa EH, Carepo MS, Moura JJ. Nitrate-nitrite fate and oxygen sensing in dormant Mycobacterium tuberculosis: A bioinorganic approach highlighting the importance of transition metals. Coordination Chemistry Reviews 2020;423:213476. [DOI: 10.1016/j.ccr.2020.213476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 6 |
Barnes M, Brisbois EJ. Clinical use of inhaled nitric oxide: Local and systemic applications. Free Radic Biol Med 2020;152:422-31. [PMID: 31785330 DOI: 10.1016/j.freeradbiomed.2019.11.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 7 |
van Teijlingen Bakker N, Pearce EJ. Cell-intrinsic metabolic regulation of mononuclear phagocyte activation: Findings from the tip of the iceberg. Immunol Rev 2020;295:54-67. [PMID: 32242952 DOI: 10.1111/imr.12848] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 8 |
Abumossalam AM, Ehab A, Elhalaby HA, Mohamad MD, Elhadidy TA. Impact of Pulmonary Tuberculosis Activity on Exhaled Breath Markers Levels in the Egyptian Population. JTR 2020;08:22-32. [DOI: 10.4236/jtr.2020.81003] [Reference Citation Analysis]
|
| 9 |
Ahsan H. Potential benefits of arginine formulation in oral health care products. Oral Science International 2019;16:130-137. [DOI: 10.1002/osi2.1021] [Reference Citation Analysis]
|
| 10 |
Sovershaeva E, Kranzer K, Mchugh G, Bandason T, Majonga ED, Usmani OS, Rowland-Jones S, Gutteberg T, Flægstad T, Ferrand RA, Odland JØ. History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children. AIDS 2019;33:1711-8. [PMID: 31107249 DOI: 10.1097/QAD.0000000000002265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB. Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru. BMC Pulm Med 2019;19:40. [PMID: 30760258 DOI: 10.1186/s12890-019-0804-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Ahsan H. Amino acid arginine and adducts: autoimmune activity. J Immunoassay Immunochem 2018;39:577-94. [PMID: 30362913 DOI: 10.1080/15321819.2018.1536667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 13 |
López JW, Loader MI, Smith D, Pastorius D, Bravard M, Caviedes L, Romero KM, Clark T, Checkley W, Ticona E, Friedland JS, Gilman RH. Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis. Am J Trop Med Hyg 2018;98:1637-9. [PMID: 29714162 DOI: 10.4269/ajtmh.17-0425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 14 |
Jamaati H, Mortaz E, Pajouhi Z, Folkerts G, Movassaghi M, Moloudizargari M, Adcock IM, Garssen J. Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis. Front Microbiol 2017;8:2008. [PMID: 29085351 DOI: 10.3389/fmicb.2017.02008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 15 |
Maiocchi SL, Morris JC, Rees MD, Thomas SR. Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents. Biochem Pharmacol 2017;135:90-115. [PMID: 28344126 DOI: 10.1016/j.bcp.2017.03.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 16 |
Ralph AP. l-Arginine in Pulmonary Tuberculosis. L-Arginine in Clinical Nutrition 2017. [DOI: 10.1007/978-3-319-26009-9_47] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 17 |
Lakio S, Morton DA, Ralph AP, Lambert P. Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery. Asian Journal of Pharmaceutical Sciences 2015;10:528-40. [DOI: 10.1016/j.ajps.2015.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 18 |
Qualls JE, Murray PJ. Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration. Semin Immunopathol 2016;38:139-52. [PMID: 26490974 DOI: 10.1007/s00281-015-0534-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 19 |
Rapovy SM, Zhao J, Bricker RL, Schmidt SM, Setchell KD, Qualls JE. Differential Requirements for L-Citrulline and L-Arginine during Antimycobacterial Macrophage Activity. J Immunol 2015;195:3293-300. [PMID: 26311904 DOI: 10.4049/jimmunol.1500800] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 20 |
Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 2015;36:161-178. [PMID: 25687683 DOI: 10.1016/j.it.2015.01.003] [Cited by in Crossref: 510] [Cited by in F6Publishing: 445] [Article Influence: 63.8] [Reference Citation Analysis]
|
| 21 |
Farazi A, Shafaat O, Sofian M, Kahbazi M. Arginine adjunctive therapy in active tuberculosis. Tuberc Res Treat 2015;2015:205016. [PMID: 25734013 DOI: 10.1155/2015/205016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013;8:e80302. [PMID: 24312209 DOI: 10.1371/journal.pone.0080302] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 23 |
Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP. Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups. PLoS One 2013;8:e76077. [PMID: 24086690 DOI: 10.1371/journal.pone.0076077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 24 |
Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, Soemanto RK, Bastian I, Lumb R, Maguire GP, Eisman J, Price RN, Morris PS, Kelly PM, Anstey NM. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 2013;8:e70032. [PMID: 23967066 DOI: 10.1371/journal.pone.0070032] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 7.6] [Reference Citation Analysis]
|
